Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
To screen or nor to screen: The prostate cancer dilemma
Nelson N. Stone
, E. David Crawford
Icahn School of Medicine at Mount Sinai
Urology
Research output
:
Contribution to journal
›
Article
›
peer-review
4
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'To screen or nor to screen: The prostate cancer dilemma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Prostate Cancer Risk
100%
Prostate Cancer
100%
Prostate
66%
ERSPC
66%
Lung
33%
Prostate-specific Antigen
33%
Rate Ratio
33%
Substantial Reduction
33%
Screening Protocol
33%
Indolent Disease
33%
Quantification of Harm
33%
Medicine and Dentistry
Prostate Cancer
100%
Cancer Mortality
75%
Disease
25%
Prostate Specific Antigen
25%
Overdiagnosis
25%
Lung
25%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Cancer Mortality
75%
Disease
25%
Prostate Specific Antigen
25%
Immunology and Microbiology
Cancer Mortality
100%
Prostate
66%
Prostate Specific Antigen
33%
Psychology
Prostate Cancer
100%